PIK3CA and AKT1E17K mutations are mutually exclusive,10 and although both mutations belong to the same pathway, methylation status shows that meningiomas with driver mutations in PIK3CA are reported as benign, while those with the AKT1E17K mutation are classified as benign and intermediate4 reflecting different tumour aggressiveness. This evidence concerns the gene PIK3CA and neoplasm.